Higher zinc concentrations in hair of Parkinson’s disease are associated with psychotic complications and depression
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Higher zinc concentrations in hair of Parkinson’s disease are associated with psychotic complications and depression
Authors
Keywords
Neurodegeneration, Biomarkers, Metal imbalance, Non-motor symptoms
Journal
JOURNAL OF NEURAL TRANSMISSION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-12
DOI
10.1007/s00702-019-02041-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hair in Parkinson's disease patients exhibits differences in Calcium, Iron and Zinc concentrations measured by flame atomic absorption spectrometry − FAAS
- (2018) Altair B dos Santos et al. JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
- Iron and Parkinson's disease: A systematic review and meta-analysis
- (2017) Giovanni Mostile et al. Molecular Medicine Reports
- The psychosis spectrum in Parkinson disease
- (2017) Dominic H. ffytche et al. Nature Reviews Neurology
- Zinc in Infection and Inflammation
- (2017) et al. Nutrients
- The Emerging Role for Zinc in Depression and Psychosis
- (2017) Matthew A. Petrilli et al. Frontiers in Pharmacology
- Meta-analysis of the association between serum iron levels and Parkinson's disease: Evidence from 11 publications
- (2016) Junjie Jiao et al. BRAIN RESEARCH
- Psychosis in Parkinson's Disease: Phenomenology, Frequency, Risk Factors, and Current Understanding of Pathophysiologic Mechanisms
- (2016) Gilles Fénelon CNS SPECTRUMS
- Reply to: Serum Zinc and the Risk of Depression in Men: Observations from a 20-Year Follow-up Study
- (2015) Walter Swardfager et al. BIOLOGICAL PSYCHIATRY
- Zinc in the Glutamatergic Theory of Depression
- (2015) Katarzyna Mlyniec Current Neuropharmacology
- Role of zinc and copper ions in the pathogenetic mechanisms of Alzheimer’s and Parkinson’s diseases
- (2014) E. V. Stelmashook et al. BIOCHEMISTRY-MOSCOW
- The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment
- (2014) Felice Iasevoli et al. Current Neuropharmacology
- Dietary zinc is associated with a lower incidence of depression: Findings from two Australian cohorts
- (2014) Khanrin Phungamla Vashum et al. JOURNAL OF AFFECTIVE DISORDERS
- Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: A double-blind, randomized, placebo-controlled trial
- (2014) Zahra Solati et al. NUTRITIONAL NEUROSCIENCE
- Essential elements in depression and anxiety. Part I
- (2014) Katarzyna Młyniec et al. Pharmacological Reports
- Zinc in Depression: A Meta-Analysis
- (2013) Walter Swardfager et al. BIOLOGICAL PSYCHIATRY
- Depression and Parkinson’s Disease: Current Knowledge
- (2013) Laura Marsh Current Neurology and Neuroscience Reports
- Glutamatergic Postsynaptic Density Protein Dysfunctions in Synaptic Plasticity and Dendritic Spines Morphology: Relevance to Schizophrenia and Other Behavioral Disorders Pathophysiology, and Implications for Novel Therapeutic Approaches
- (2013) Andrea de Bartolomeis et al. MOLECULAR NEUROBIOLOGY
- Decreased iron levels in the temporal cortex in postmortem human brains with Parkinson disease
- (2013) X. Yu et al. NEUROLOGY
- Effects of zinc supplementation on efficacy of antidepressant therapy, inflammatory cytokines, and brain-derived neurotrophic factor in patients with major depression
- (2013) Elham Ranjbar et al. NUTRITIONAL NEUROSCIENCE
- Assessing Plasma Levels of Selenium, Copper, Iron and Zinc in Patients of Parkinson’s Disease
- (2013) Hai-Wen Zhao et al. PLoS One
- Metal ions as modulators of protein conformation and misfolding in neurodegeneration
- (2012) Sónia S. Leal et al. COORDINATION CHEMISTRY REVIEWS
- Frequency, prevalence, incidence and risk factors associated with visual hallucinations in a sample of patients with Parkinson's disease: a longitudinal 4-year study
- (2012) G. Gibson et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Phosphorylated -Synuclein in Parkinson's Disease
- (2012) Y. Wang et al. Science Translational Medicine
- Glutamate Neurocircuitry: Theoretical Underpinnings in Schizophrenia
- (2012) Thomas L. Schwartz et al. Frontiers in Pharmacology
- The efficacy of zinc supplementation in depression: Systematic review of randomised controlled trials
- (2011) Jun Lai et al. JOURNAL OF AFFECTIVE DISORDERS
- The pedunculopontine nucleus is related to visual hallucinations in Parkinson’s disease: preliminary results of a voxel-based morphometry study
- (2011) J. Janzen et al. JOURNAL OF NEUROLOGY
- Dietary intake of metals and risk of Parkinson's disease: A case-control study in Japan
- (2011) Yoshihiro Miyake et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis
- (2010) Guochuan Tsai et al. CURRENT PHARMACEUTICAL DESIGN
- The involvement of NMDA and AMPA receptors in the mechanism of antidepressant-like action of zinc in the forced swim test
- (2009) B. Szewczyk et al. AMINO ACIDS
- Abnormal sleep and sleepiness in Parkinsonʼs disease
- (2009) Isabelle Arnulf et al. CURRENT OPINION IN NEUROLOGY
- Epidemiology of psychosis in Parkinson's disease
- (2009) Gilles Fénelon et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease
- (2009) Paolo Barone et al. MOVEMENT DISORDERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now